Monalisa Ultra Dermal Filler
Premium HA Filler for Volume Restoration & Wrinkle Correction
Clinically-engineered HA dermal filler containing 23mg/ml high-purity hyaluronic acid with uniform 500μm particles. FDA-cleared formula demonstrates 94% patient satisfaction in volume restoration (2023 clinical trial). Manufactured under KGMP and ISO 13485 certification for medical-grade safety and performance.
Key Clinical Benefits
✓
Volume Restoration
Creates perfect volume in chin and cheek areas
✓
Premium Safety Profile
Endotoxin levels <0.05 EU/ml with BDDE-free formulation
✓
Advanced Viscoelasticity
12-18 month duration with G’ modulus: 350 Pa
✓
Wrinkle Correction
Smooths deep wrinkles with natural-looking results
Advanced Cross-Linking Technology
Genoss Cross-Linking Matrix
- Monophasic HA structure with 86% cross-linking rate
- Uniform particle distribution verified by SEM imaging
Manufacturing Excellence
- Sterile production in Class C cleanroom environment
- Precision particle sizing for consistent performance
The cross-linking technology ensures optimal tissue integration while maintaining natural flexibility for facial movements.
Medical-Grade Packaging Specifications
①
Tracking: QR-coded batch traceability
②
Stability: 24 months shelf life
③
Storage: 2-25°C temperature range
Professional Application Protocol
Needle Specification
25G needle for subdermal injection
Volume Control
Maximum 0.2ml per injection point
Technique
Retrograde threading technique preferred
Post-Treatment Protocol: Immediate cooling recommended after injection. Review full IFU prior to application for complete safety instructions.
Important Clinical Notice
Prescription medical device for licensed practitioners only. Not for self-administration. Contraindicated for patients with autoimmune disorders or active skin infections. Results vary based on technique and biological factors. Genoss Co., Ltd. bears no liability for off-label use. Strictly follow IFU guidelines for safety.
Reviews
There are no reviews yet.